Acacia research corp (ACTG)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Cash flows from operating activities:
Net loss including noncontrolling interests in subsidiaries

-17,129

-104,848

-

-

-

-

-

-

-

-

-

Net loss including noncontrolling interests in subsidiaries

-

-

21,684

-54,799

-157,478

-66,662

-58,842

59,289

21,645

37,016

-5,633

Adjustments to reconcile net loss including noncontrolling interests in subsidiaries to net cash provided by (used in) operating activities:
Gain on Conversion of Loan and Accrued Interest

-

-

2,671

0

0

-

-

-

-

-

-

Gain on exercise of Primary Warrant

-

-

4,616

0

0

-

-

-

-

-

-

Change in fair value of investment

-

-

42,239

0

0

-

-

-

-

-

-

Gain on investments

-

-

-

-

-

-

-

-

-

-

-47

Change in fair value of investment, net (Note 5)

9,899

-59,103

-

-

-

-

-

-

-

-

-

Loss on sale of investment (Note 5)

9,230

19,095

0

-

-

-

-

-

-

-

-

Impairment of other investment (Note 6)

8,195

1,000

-

-

-

-

-

-

-

-

-

Gain on disposal of other investment (Note 6)

2,000

0

-

-

-

-

-

-

-

-

-

Depreciation and amortization

3,227

27,145

-

-

-

-

-

-

-

-

-

Change in fair value of Series A redeemable convertible preferred stock embedded derivative

3,258

0

-

-

-

-

-

-

-

-

-

Change in fair value of Series A warrants

1,260

0

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

22,243

34,355

53,289

54,049

49,275

39,168

9,850

7,017

4,759

Non-cash stock compensation

1,075

-317

8,885

9,062

11,048

18,115

27,894

25,657

13,579

7,121

7,065

Change in value of trading securities

2,241

0

-

-

-

-

-

-

-

-

-

Impairment of Patent-Related Intangible Assets

-

-

2,248

42,340

74,731

3,497

4,619

-

-

-

-

Impairment of Goodwill

-

-

-

0

30,149

0

0

-

-

-

-

Impairment of patent-related intangible assets

0

28,210

-

-

-

-

-

-

-

-

-

Deferred revenues

-

-

-

-

-

-

-

-

-

-1,510

1,192

Deferred income tax

-

-

-

-

-

-

-

-

0

0

-

Other

0

-436

-374

-477

-109

-28

12

777

-15

-32

-

Changes in assets and liabilities:
Increase (Decrease) in Restricted Cash

-

-

-

-787

-10,725

0

0

-

-

-

-

Accounts receivable

-32,373

28,189

26,597

6,750

-13,332

-13,827

3,502

-6,928

5,072

-2,877

-2,326

Prepaid expenses and other assets

220

208

-135

1,593

-619

3,154

-5,300

-1,294

1,075

-757

106

Accounts payable and accrued expenses

109

963

-6,349

-3,006

2,570

3,718

2,740

2,255

-781

-1,414

4,836

Royalties and contingent legal fees payable

-20,510

19,359

-12,307

-970

527

3,904

-2,061

-11,000

10,748

358

1,632

Net cash used in operating activities

-2,308

20,877

12,966

34,061

-9,949

4,184

-3,509

104,603

60,590

44,922

16,118

Cash flows from investing activities:
Patent acquisition costs

4,420

0

-

1,225

19,504

42,746

25,061

178,260

14,680

8,224

9,625

Sale of investment at fair value (Note 5)

6,628

19,097

-

-

-

-

-

-

-

-

-

(Purchase) Sale of other Investments (Note 6)

-2,000

7,000

-

-

-

-

-

-

-

-

-

Purchases of trading securities

147,178

102,769

-

-

-

-

-

-

-

-

-

Proceeds from Sale and Maturity of Marketable Securities

-

-

-

43,232

82,115

-

-

-

-

-

-

Payments to Acquire Businesses, Net of Cash Acquired

-

-

-

-

-

-

-

150,000

0

0

-

Payments to Acquire Other Investments

-

-

31,514

0

0

-

-

-

-

-

-

Purchases of available-for-sale investments

-

-

448,388

62,633

23,296

109,963

279,693

402,500

8,427

0

0

Maturities and sales of trading securities

75,090

66,640

-

-

-

-

-

-

-

-

-

Maturities and sale of available-for-sale investments

-

-

467,790

43,232

82,115

182,115

239,370

322,236

60

184

1,040

Purchases of property and equipment

183

34

2

4

8

109

675

268

190

58

67

Payments to Acquire Investments

-

-

-

-

-

0

-

-

-

-

-

Net cash provided by (used in) investing activities

-68,063

-24,066

-16,114

-40,630

39,307

29,297

-66,059

-408,792

-23,237

-8,098

-8,652

Cash flows from financing activities:
Repurchase of restricted common stock

-

-

-45

-

-

-

-

-

-

-

-

Repurchase of common stock

-

-

-

-

-

-

-

218,961

175,229

0

0

Repurchase of common stock

0

4,634

0

82

0

0

7,926

26,732

0

0

1,107

Repurchase of restricted common stock

0

229

-

-

-

-

-

-

-

-

-

Issuance of redeemable convertible preferred stock and Series A warrants, net of issuance costs

33,842

0

-

-

-

-

-

-

-

-

-

Dividend on Series A Redeemable Convertible Preferred Stock

-

-

-

0

25,434

25,039

18,633

0

0

-

-

Distributions to noncontrolling interests in operating subsidiary

-

-

-

1,358

4,105

867

0

312

2,897

4,807

3,150

Proceeds from exercise of stock options

79

257

745

326

938

206

486

340

411

15,068

247

Contributions from noncontrolling interests in operating subsidiary, net of issuance costs

-

-

-

-

-

-

1,920

5,793

1,539

2,393

0

Excess tax benefits from stock-based compensation

-

-

-

-

-

-

-1,398

13,210

583

1,302

0

Net cash provided by financing activities

33,921

-4,606

700

-1,114

-28,601

-25,700

-25,551

211,260

174,865

13,956

-4,010

Increase (decrease) in cash and cash equivalents and restricted cash

-36,450

-7,795

-

-

-

-

-

-

-

-

-

Decrease in cash and cash equivalents

-

-

-2,448

-7,683

757

7,781

-95,119

-92,929

212,218

50,780

3,456

Excess tax benefits from stock-based compensation

-

-

-

-

-

-

1,398

-13,210

-583

-

-

Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount

-

-

-

-

-

-1,736

-26,746

9,889

0

0

-

Proceeds from Sale of Other Assets, Investing Activities

-

-

0

-

-

-

-

-

-

-

-

Payments to Acquire Notes Receivable

-

-

4,000

20,000

0

-

-

-

-

-

-

Patent acquisition costs included in accrued expenses

-

-

-

0

1,000

16,700

4,000

0

900

-

-